Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Clinical trial NCT01934465 · COMPLETED

Trial details

NCT number: NCT01934465
Sponsor: Hellenic Oncology Research Group
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2010-02-01
Primary completion: 2013-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.